Erschienen in:
01.03.2007 | Letter
Comment on: Distiller LA, Joffe BI (2006) From the coalface: does glargine insulin improve hypoglycaemic episodes, glycaemic control or affect body mass in type 1 diabetic subjects who are attending a ‘routine’ diabetes clinic? Diabetologia 49:2793–2794
verfasst von:
D. S. H. Bell
Erschienen in:
Diabetologia
|
Ausgabe 3/2007
Einloggen, um Zugang zu erhalten
Excerpt
To the Editor: Distiller and Joffe reported that type 1 diabetic patients being treated in a ‘real-world’ environment with basal-bolus therapy did not achieve better glycaemic control when converted from NPH to glargine insulin [
1]. Prior to changing to glargine, 32.2% of these type 1 diabetic subjects were receiving an NPH injection more frequently than once daily. …